Center-Authored Papers

Filters: Author is Bernstein, Jonine L  [Clear All Filters]
2008
Concannon P, Haile RW, Børresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B et al..  2008.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.. Cancer research. 68(16):6486-91. Abstract
Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B et al..  2008.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.. Journal of the National Cancer Institute. 100(1):32-40. Abstract
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF et al..  2008.  Variation of breast cancer risk among BRCA1/2 carriers.. JAMA : the journal of the American Medical Association. 299(2):194-201. Abstract
Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Bertelsen L, Haile RW, Bernstein JL.  2008.  Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(9):1411-8. Abstract
Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF et al..  2008.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study.. International journal of radiation oncology, biology, physics. 72(4):1021-30. Abstract
2009
Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X et al..  2009.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.. American journal of epidemiology. 169(8):962-8. Abstract
2010
Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH et al..  2010.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.. Journal of the National Cancer Institute. 102(7):475-83. Abstract
Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P et al..  2010.  Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.. Breast cancer research and treatment. 120(1):175-83. Abstract
Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN et al..  2010.  Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.. Cancer causes & control : CCC. 21(6):839-46. Abstract
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P et al..  2010.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.. Human mutation. 31(3):E1200-40. Abstract
Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al..  2010.  Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(14):2404-10. Abstract
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
2011
Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC et al..  2011.  Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.. Genetic epidemiology. 35(5):389-97. Abstract
Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A et al..  2011.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.. Breast cancer research and treatment. 127(3):819-29. Abstract
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X et al..  2011.  Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study.. Breast cancer research : BCR. 13(6):R114. Abstract
2012
Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, Bernstein JL et al..  2012.  Body mass index and risk of second primary breast cancer: The WECARE Study.. Breast cancer research and treatment. 131(2):571-80. Abstract
Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjaer L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P et al..  2012.  Variation in genes related to obesity, weight and weight change and risk of contralateral breast cancer in the WECARE Study population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(12):2261-2267. Abstract
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S et al..  2012.  Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.. Human mutation. 33(1):158-164. Abstract
2013
Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P et al..  2013.  Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.. International journal of molecular epidemiology and genetics. 4(1):35-48. Abstract
Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ et al..  2013.  Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.. Cancer causes & control : CCC. 24(8):1605-14. Abstract
Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS et al..  2013.  Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report.. European journal of cancer (Oxford, England : 1990). 49(14):2979-2985. Abstract
2014
Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Friedman DN, Mubdi NZ, Leisenring WM, Stovall M, Hammond S et al..  2014.  Breast Cancer After Chest Radiation Therapy for Childhood Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
2015
Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M et al..  2015.  Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.. SpringerPlus. 4:825. Abstract
2016
Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS et al..  2016.  Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.. Breast cancer research : BCR. 18(1):65. Abstract
Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE et al..  2016.  Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.. Cancer medicine. 5(11):3282-3291. Abstract